SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001387131-22-007476
Filing Date
2022-07-06
Accepted
2022-07-06 06:04:56
Documents
5

Document Format Files

Seq Description Document Type Size
1 ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS admp-defa14a_063022.htm DEFA14A 72647
2 CERTIFICATE OF DESIGNATION ex3-1.htm EX-3.1 115168
3 COMMON STOCK PURCHASE WARRANT ex4-1.htm EX-4.1 128033
4 SECURITIES PURCHASE AGREEMENT ex10-1.htm EX-10.1 240278
5 REGISTRATION RIGHTS AGREEMENT ex10-2.htm EX-10.2 175703
  Complete submission text file 0001387131-22-007476.txt   732931
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36242 | Film No.: 221067334
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences